Israel Cancer Research Fund Inc
- Assets
- $17.0m
- Revenue
- $7.1m
- Investments
- $0.0
- Employees
- 16
- Location
- New York, NY
- Founding
- 02/1976
- Data as of
- 12/2021
- EIN
- 51-0181215
Organization Overview
Israel Cancer Research Fund Inc is located in New York, NY. The organization was established in 1976. According to its NTEE Classification (H12) the organization is classified as: Fund Raising & Fund Distribution, under the broad grouping of Medical Research and related organizations. As of 12/2021, Israel Cancer Research Fund Inc employed 16 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Israel Cancer Research Fund Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, Israel Cancer Research Fund Inc generated $7.1m in total revenue. This represents relatively stable growth, over the past 7 years the organization has increased revenue by an average of 2.6% each year. All expenses for the organization totaled $5.4m during the year ending 12/2021. While expenses have increased by 1.9% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
TO SUPPORT CANCER RESEARCH IN ISRAEL, FOR THE BENEFIT OF ISRAEL AND ALL MANKIND.
Describe the Organization's Program Activity:
Part 3 - Line 4a
PROVIDE CANCER RESEARCH FUNDING FOR ISRAELI SCIENTISTS. ICRF IS THE LARGEST NON-PROFIT IN NORTH AMERICA DEDICATED TO SUPPORTING CANCER RESEARCH IN ISRAEL. OVER THE LAST 40 YEARS, ICRF HAS PROVIDED MORE THAN $87.5 MILLION TO SUPPORT CANCER RESEARCH IN ISRAEL, FUNDING OVER 2,700 RESEARCH PROJECTS AT ALL OF THE MAJOR ISRAELI RESEARCH INSTITUTIONS. TYPICALLY, 60-80 GRANTS ARE FUNDED ANNUALLY, BASED ON AN EVALUATION AND PRIORITIZATION BY INDEPENDENT REVIEW PANELS CONSISTING OF 40-50 LEADING CANCER SCIENTISTS FROM NORTH AMERICAN BIOMEDICAL RESEARCH CENTERS. ICRF GRANT CATEGORIES ARE TAILORED TO SUPPORT CANCER RESEARCHERS AT ALL OF THE VARIOUS STAGES OF THEIR CAREERS, AND WE ARE PROUD TO HAVE HELPED SUPPORT MANY OF TODAY'S MOST OUTSTANDING SCIENTISTS AT THE EARLIEST STAGES IN THEIR CAREERS. ICRF SEEKS TO CAPITALIZE ON THE SIGNIFICANTLY LOWER COSTS OF CONDUCTING CANCER RESEARCH IN ISRAEL. ALL AWARDS GO DIRECTLY TO THE DESIGNATED RESEARCHER WITHOUT ANY REDUCTION FOR OVERHEAD. IN 2021, WE AWARDED 49 RESEARCH GRANTS VALUED AT NEARLY $2.795M.
SUPPORT THE DEVELOPMENT OF THE NEXT GENERATION OF ISRAELI CANCER SCIENTISTS. ICRF IS COMMITTED TO FACILITATING THE DEVELOPMENT OF FUTURE CANCER SCIENTISTS IN ISRAEL. TOWARDS THIS END ICRF FUNDS THREE TYPES OF GRANTS: POSTDOCTORAL FELLOWSHIP AWARDS, RESEARCH CAREER DEVELOPMENT AWARDS, AND CLINICAL RESEARCH CAREER DEVELOPMENT AWARDS. FELLOWSHIPS SUPPORT MDS AND PHDS WHO HAVE JUST COMPLETED THEIR POSTGRADUATE TRAINING. THESE AWARDS CAN BE USED TO SUPPORT SALARIES OR RESEARCH COSTS, WHILE THESE INDIVIDUALS APPRENTICE IN THE LABORATORIES OF SENIOR INVESTIGATORS. CAREER DEVELOPMENT AWARDS ARE TO ENHANCE THE RESEARCH CAPABILITIES OF YOUNG ISRAELI SCIENTISTS IN THE FORMATIVE PHASE OF THEIR CAREERS. CANDIDATES MUST HAVE DEMONSTRATED OUTSTANDING POTENTIAL FOR CONTRIBUTIONS TO CANCER RESEARCH AND MUST EXHIBIT GREAT POTENTIAL TO BECOME INDEPENDENT INVESTIGATORS RESEARCH. SUPPORTING THESE NEWLY LAUNCHED SCIENTISTS, ENHANCES THEIR OPPORTUNITIES IN ISRAEL AND ALLOWS THEM TO OPTIMIZE THEIR WORK WITHOUT EMIGRATING TO OTHER ADVANCED COUNTRIES.
SUPPORT COLLABORATIVE CANCER RESEARCH CONDUCTED BY ISRAELI SCIENTISTS IN ASSOCIATION WITH NORTH AMERICAN CANCER SCIENTISTS. CANCER SCIENCE OFTENTIMES REQUIRES MULTI-DISCIPLINARY APPROACHES, ENGAGEMENT WITH HIGHLY SPECIALIZED AREAS OF SCIENCE, AND EXPENSIVE EQUIPMENT THAT IS NOT EASILY ACCESSED. COLLABORATIONS BETWEEN SCIENTISTS IN ISRAEL AND NORTH AMERICA CAN ADDRESS THESE CHALLENGES, FOSTER UNEXPECTED SYNERGIES, AND ENHANCE BOTH INTELLECTUAL CURIOSITY AND INNOVATION. ICRF PROMOTES COLLABORATION BY SUPPORTING GRANTS THAT FUND PROMISING CANCER RESEARCH PROJECTS BEING CONDUCTED ON A COLLABORATIVE BASIS BETWEEN INVESTIGATORS IN ISRAEL AND AN AMERICAN OR CANADIAN RESEARCH INSTITUTION.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Beryl Chernov National Executive Directo | Officer | 40 | $223,750 |
Caitlin Shmidheiser Chief Development Officer | Officer | 40 | $185,400 |
Allyson Marks-Greenfield Executive Director, Chicag | 40 | $175,100 | |
Kenneth Gabel New York Director | 40 | $139,675 | |
Margaret Porta Controller | 40 | $137,629 | |
David Kweskin Connecticut Director | 40 | $113,956 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $1,793,638 |
| Related organizations | $0 |
| Government grants | $248,381 |
| All other contributions, gifts, grants, and similar amounts not included above | $4,911,296 |
| Noncash contributions included in lines 1a–1f | $53,342 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $6,953,315 |
| Total Program Service Revenue | $0 |
| Investment income | $202,683 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | -$9,496 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $7,146,502 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $2,795,000 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $409,150 |
| Compensation of current officers, directors, key employees. | $81,830 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $1,122,737 |
| Pension plan accruals and contributions | $27,023 |
| Other employee benefits | $124,281 |
| Payroll taxes | $111,317 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $14,924 |
| Fees for services: Accounting | $33,804 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $65,532 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $129,602 |
| Advertising and promotion | $31,241 |
| Office expenses | $129,583 |
| Information technology | $39,954 |
| Royalties | $0 |
| Occupancy | $236,464 |
| Travel | $3,313 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $21,424 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $27,799 |
| Insurance | $0 |
| All other expenses | $0 |
| Total functional expenses | $5,411,705 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $1,396,320 |
| Savings and temporary cash investments | $1,469,319 |
| Pledges and grants receivable | $2,050,733 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $106,975 |
| Net Land, buildings, and equipment | $326,337 |
| Investments—publicly traded securities | $11,617,585 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $48,487 |
| Total assets | $17,015,756 |
| Accounts payable and accrued expenses | $418,309 |
| Grants payable | $1,340,000 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $265,921 |
| Total liabilities | $2,024,230 |
| Net assets without donor restrictions | $7,669,611 |
| Net assets with donor restrictions | $7,321,915 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $17,015,756 |
Grants Awarded
Over the last fiscal year, Israel Cancer Research Fund Inc has awarded $60,000 in support to 2 organizations.
| Grant Recipient | Amount |
|---|---|
UNIVERSITY OF WASHINGTON PURPOSE: CANCER RESEARCH | $30,000 |
Somerville, MA PURPOSE: CANCER RESEARCH | $30,000 |
Grants Recieved
Over the last fiscal year, we have identified 3 grants that Israel Cancer Research Fund Inc has recieved totaling $18,688.
| Awarding Organization | Amount |
|---|---|
Samuel Epstein Foundation Trust Pittsburgh, PA PURPOSE: GENERAL SUPPORT | $15,113 |
Akers Foundation Chicago, IL PURPOSE: TO PROMOTE CANCER RESEARCH | $2,575 |
Selkowitz Family Foundation Stamford, CT PURPOSE: HELP SUPPORT CANCER RESEARCH | $1,000 |
Endowment Analysis
| Beg. Balance | $3,311,782 |
| Earnings | $441,514 |
| Ending Balance | $3,753,296 |
Peer Organizations
| Organization Name | Assets | Revenue |
|---|---|---|
Health Effects Institute Boston, MA | $12,526,721 | $12,481,645 |
The Association For Frontotemporal Degeneration King Of Prussia, PA | $44,796,969 | $12,057,958 |
Childrens Oncology Group Foundation Philadelphia, PA | $22,837,173 | $7,487,855 |
Hope For Depression Research Foundation New York, NY | $59,831,359 | $6,866,948 |
Israel Cancer Research Fund Inc New York, NY | $17,015,756 | $7,146,502 |
Life Science Cares Inc Cambridge, MA | $8,104,702 | $8,289,428 |
Haymakers For Hope Inc Wellesley, MA | $644,411 | $4,070,620 |
Fox Chase Cancer Center Foundation Philadelphia, PA | $63,333,365 | $6,307,847 |
The Progeria Research Foundation Inc Peabody, MA | $53,690,802 | $49,219,762 |
Improvecarenow Inc Essex, VT | $802,029 | $3,120,134 |
Dubai Harvard Foundation For Medical Research Inc Boston, MA | $15,096,309 | $431,547 |
The Curetivity Foundation Darien, CT | $568,541 | $2,365,515 |